Cargando…
Biguanides and targeted anti-cancer treatments
Autores principales: | Hanly, Elyse K., Darzynkiewicz, Zbigniew, Tiwari, Raj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426946/ https://www.ncbi.nlm.nih.gov/pubmed/26000092 |
Ejemplares similares
-
Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells
por: Hanly, Elyse K., et al.
Publicado: (2015) -
mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib
por: Hanly, Elyse K., et al.
Publicado: (2015) -
Disruption of mutated BRAF signaling modulates thyroid cancer phenotype
por: Hanly, Elyse K, et al.
Publicado: (2014) -
microRNA-494 and ATF3 the targets of onconase(?)
por: Darzynkiewicz, Zbigniew
Publicado: (2016) -
Contact allergy to polyhexamethylene biguanide (polyaminopropyl biguanide)
por: Sukakul, Thanisorn, et al.
Publicado: (2020)